文献速递其他结缔组织病

韩国肌炎患者HLA区域新的易感等位基因及其与肌炎特异性抗体的关联

Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients.
PubMed 文献 · Semin Arthritis Rheum · 2019-03-09

该研究首次在韩国人群中大规模检测179例皮肌炎或多发性肌炎患者及健康对照的HLA-DRB1和HLA-DPB1等位基因与肌炎特异性抗体(MSA),发现HLA-DRB1*12:02与皮肌炎相关、HLA-DRB1*14:03与多发性肌炎相关,并鉴定出多个与MSA相关的HLA等位基因,提示韩国肌炎患者具有独特的免疫遗传背景。

要点

  • HLA-DRB1*12:02与皮肌炎相关,HLA-DRB1*14:03与多发性肌炎相关。
  • HLA-DRB1*12:02与抗MDA5抗体相关,HLA-DRB1*08:03与抗ARS抗体相关。
  • HLA-DRB1*14:03与抗SRP抗体相关,HLA-DRB1*07:01与抗Mi2抗体相关。

核心结论

  • 韩国肌炎患者具有独特的免疫遗传背景,鉴定出HLA-DRB1*12:02和HLA-DRB1*14:03等新的肌炎易感等位基因及韩国患者特有的MSA相关HLA等位基因。

研究设计与样本

  • 研究为韩国人群首次大规模HLA基因分型研究,纳入179例皮肌炎(DM,n=129)或多发性肌炎(PM,n=50)患者,HLA-DRB1对照800例、HLA-DPB1对照548例,比较患者与对照间各HLA等位基因与肌炎/MSA的关联,多重检验采用Bonferroni校正。

主要发现

  • 共对患者和对照进行33个HLA-DRB1和24个HLA-DPB1等位基因分型,67.0%的患者检出MSA。
  • MSA以抗MDA5(26.8%)和抗氨基酰tRNA合成酶抗体(15.6%)最常见,其次为抗Mi2(9.5%)和抗TIF1γ抗体(8.9%)。
  • HLA-DRB1*12:02与DM相关,HLA-DRB1*14:03与PM相关。
  • HLA-DRB1*12:02与抗MDA5相关,HLA-DRB1*08:03与抗ARS相关,HLA-DRB1*14:03与抗SRP相关,HLA-DRB1*07:01与抗Mi2抗体相关。
  • HLA-DRB1*13:01与抗TIF1γ抗体相关但其频率罕见;HLA-DPB1*02:01与肌炎及PM呈负相关,HLA-DPB1*17:01与抗Mi2阳性DM相关。

关键数值与推荐

  • 患者中MSA检出率为67.0%,抗MDA5为26.8%,抗氨基酰tRNA合成酶抗体为15.6%,抗Mi2为9.5%,抗TIF1γ抗体为8.9%。
  • HLA-DRB1对照800例,HLA-DPB1对照548例,患者179例(DM 129例、PM 50例)。

临床怎么用

  • 在韩国肌炎患者中可关注HLA-DRB1*12:02与DM、HLA-DRB1*14:03与PM的关联,并注意MSA与特定HLA等位基因的对应关系以辅助临床评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: HLA genes are a major genetic risk factor for myositis and myositis specific antibodies (MSAs), exhibiting unique HLA backgrounds for myositis in different ethnic groups. This is the first large scale Korean study to genotype the HLA-DRB1 and -DPB1 alleles and to examine their association with myositis and MSAs. METHODS: HLA-DRB1 and HLA-DPB1 alleles and MSAs were examined in 179 patients with dermatomyositis (DM, n = 129) or polymyositis (PM, n = 50) and healthy controls (n = 800 for HLA-DRB1, n = 548 for HLA-DPB1). Associations between individual HLA alleles and myositis/MSA were examined. Bonferroni correction was applied for multiple testing comparing patients and controls. RESULTS: A total of 33 HLA-DRB1 and 24 HLA-DPB1 alleles were genotyped in patients and controls. MSAs were found in 67.0% of patients. Anti-MDA5 (26.8%) and anti-aminoacyl-tRNA synthetase antibodies (15.6%) were most common, followed by anti-Mi2 (9.5%) and anti-TIF1γ antibodies (8.9%). HLA-DRB1*12:02 and HLA-DRB1*14:03 were associated with DM and PM, respectively. HLA-DRB1*12:02 was associated with anti-MDA5, HLA-DRB1*08:03 with anti-ARS, HLA-DRB1*14:03 with anti-SRP, and HLA-DRB1*07:01 with anti-Mi2 antibodies. Although HLA-DRB1*13:01 was associated with anti-TIF1γ antibodies, the frequency of HLA-DRB1*13:01 was rare. HLA-DPB1*02:01 was negatively associated with myositis and PM while HLA-DPB1*17:01 was associated with anti-Mi2 positive DM. CONCLUSIONS: Unique immunogenetic background was observed for Korean patients with myositis. Novel myositis susceptibility alleles, HLA-DRB1*12:02 and HLA-DRB1*14:03, were identified, together with MSA-associated HLA alleles unique to Korean patients with myositis.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Kang EH, Go DJ, Mimori T, et al. Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients. Semin Arthritis Rheum. 2019. PMID: 30952422. doi:10.1016/j.semarthrit.2019.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。